Polymorphic forms of a known antihyperlipemic agent

Details for Australian Patent Application No. 2004274239 (hide)

Owner AstraZeneca UK Limited

Inventors Owens, Lianne; Black, Simon Nicholas; Warren, Kenneth Edwin Herbert; Taylor, Nigel Philip

Agent Davies Collison Cave

Pub. Number AU-B-2004274239

PCT Pub. Number WO2005/028450

Priority 0321827.8 18.09.03 GB

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 4 December 2008

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/028450 Priority application(s): WO2005/028450

4 December 2008 Application Accepted

  Published as AU-B-2004274239

2 April 2009 Standard Patent Sealed

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274240-Improved universal vehicle engine, gearbox and like stand

2004274230-Derivatives of N-(1H-indazolyl)- and N- (1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain